| 1 | Gastrointestinal Neoplasms | 44.2% |
| 2 | Peritoneal Neoplasms | 43.6% |
| 3 | Pancreatic Neoplasm | 38.3% |
| 4 | Esophageal Neoplasms | 34.2% |
| 5 | Bile Duct Neoplasms | 33.3% |
| 6 | gallbladder neoplasm | 33.3% |
| 7 | Intestinal Neoplasms | 33.3% |
| 8 | Stomach Neoplasms | 33.3% |
| 9 | Biliary cirrhosis | 32.1% |
| 10 | Colorectal Neoplasms | 28.4% |
| 11 | Fatty Liver | 28.1% |
| 12 | Hepatitis | 28.1% |
| 13 | Portal Hypertension | 28.1% |
| 14 | Liver Cirrhosis | 28.1% |
| 15 | Focal Nodular Hyperplasia | 28.1% |
| 16 | Hepatic Insufficiency | 28.1% |
| 17 | Steatohepatitis | 28.1% |
| 18 | Cecal Neoplasms | 28% |
| 19 | Duodenal Neoplasms | 28% |
| 20 | Zollinger-Ellison syndrome | 27.8% |
| 21 | Fatty Liver, Alcoholic | 27% |
| 22 | Hepatitis, Alcoholic | 27% |
| 23 | Liver Cirrhosis, Alcoholic | 27% |
| 24 | Appendiceal Neoplasms | 24.9% |
| 25 | Colonic Neoplasms | 24.9% |
| 26 | Rectal Neoplasms | 24.9% |
| 27 | Esophageal and Gastric Varices | 24.7% |
| 28 | Anus Neoplasms | 24% |
| 29 | Sigmoid Neoplasms | 24% |
| 30 | Carcinoma, Pancreatic Ductal | 23.5% |
| 31 | Liver Diseases, Parasitic | 23.2% |
| 32 | Hepatic Veno-Occlusive Disease | 22.5% |
| 33 | Peliosis Hepatis | 22.5% |
| 34 | Hepatopulmonary Syndrome | 22.5% |
| 35 | Hepatomegaly | 22.2% |
| 36 | Gastrointestinal Stromal Tumors | 22% |
| 37 | Hepatic Vein Thrombosis | 22% |
| 38 | Liver Abscess | 22% |
| 39 | Budd-Chiari Syndrome | 22% |
| 40 | Biliary Tract Diseases | 21.8% |
| 41 | Gastrointestinal Diseases | 21.8% |
| 42 | Pancreatic Diseases | 21.8% |
| 43 | Adenomatous Polyposis Coli | 21.8% |
| 44 | insulinoma | 21% |
| 45 | Gastrinoma | 20.9% |
| 46 | Glucagonoma | 20.9% |
| 47 | Hepatitis, Chronic | 20.7% |
| 48 | Liver Failure | 20.7% |
| 49 | Non-alcoholic Fatty Liver Disease | 20.7% |
| 50 | Chronic active hepatitis | 20.7% |
| 51 | Liver Abscess, Amebic | 20.4% |
| 52 | Vipoma | 19.5% |
| 53 | Proctocolitis | 19.4% |
| 54 | Chemical and Drug Induced Liver Injury | 18.8% |
| 55 | Pancreatic Fistula | 18.5% |
| 56 | Hepatorenal Syndrome | 18.3% |
| 57 | Hepatitis B, Chronic | 18.1% |
| 58 | Hepatitis C, Chronic | 18.1% |
| 59 | Hepatitis, Animal | 17.1% |
| 60 | Hepatitis, Viral, Human | 17.1% |
| 61 | Liver Failure, Acute | 17.1% |
| 62 | End Stage Liver Disease | 17.1% |
| 63 | Choledochal Cyst | 16.8% |
| 64 | Duodenitis | 16.8% |
| 65 | Ileitis | 16.8% |
| 66 | Erosive Duodenitis | 16.8% |
| 67 | Dysentery | 16.4% |
| 68 | Enteritis | 16.4% |
| 69 | Enterocolitis | 16.4% |
| 70 | Esophagitis | 16.4% |
| 71 | Gastritis | 16.4% |
| 72 | Inflammatory Bowel Diseases | 16.4% |
| 73 | Liver Cirrhosis, Experimental | 16.4% |
| 74 | Cholecystolithiasis | 16.4% |
| 75 | Mesenteric vascular insufficiency | 16.3% |
| 76 | Esophageal Atresia | 16.1% |
| 77 | Intestinal Atresia | 16.1% |
| 78 | Mesenteric Vascular Occlusion | 16.1% |
| 79 | Intestinal Fistula | 16% |
| 80 | Enterocutaneous Fistula | 16% |
| 81 | Abdominal Neoplasms | 15.8% |
| 82 | Head and Neck Neoplasms | 15.8% |
| 83 | Soft Tissue Neoplasms | 15.8% |
| 84 | Thoracic Neoplasms | 15.8% |
| 85 | Porphyrias, Hepatic | 15.7% |
| 86 | Pancreatic Cyst | 15.5% |
| 87 | Massive Hepatic Necrosis | 15.3% |
| 88 | Rectal Fistula | 15.3% |
| 89 | Anal Fistula | 15.3% |
| 90 | Colitis | 15% |
| 91 | Duodenogastric Reflux | 15% |
| 92 | Peptic Ulcer | 15% |
| 93 | Proctitis | 15% |
| 94 | Choledocholithiasis | 15% |
| 95 | Pouchitis | 15% |
| 96 | Bile Duct Diseases | 14% |
| 97 | Cholelithiasis | 14% |
| 98 | Chylous Ascites | 14% |
| 99 | Esophageal Diseases | 14% |
| 100 | Gastroenteritis | 14% |
| 101 | Intestinal Diseases | 14% |
| 102 | Pancreatic Insufficiency | 14% |
| 103 | Pancreatitis | 14% |
| 104 | Pneumoperitoneum | 14% |
| 105 | Stomach Diseases | 14% |
| 106 | Fascioliasis | 13.8% |
| 107 | Autoimmune hepatitis | 13.8% |
| 108 | Echinococcosis, Hepatic | 13.7% |
| 109 | Chemical and Drug Induced Liver Injury, Chronic | 13.6% |
| 110 | Reye Syndrome | 13.6% |
| 111 | Crohn Disease | 13.5% |
| 112 | Duodenal Obstruction | 13.5% |
| 113 | Enterocolitis, Neutropenic | 13.5% |
| 114 | Necrotizing Enterocolitis | 13.5% |
| 115 | Endocrine Gland Neoplasms | 13% |
| 116 | Eye Neoplasms | 13% |
| 117 | Nervous System Neoplasms | 13% |
| 118 | Duodenal Ulcer | 12.8% |
| 119 | Peptic Ulcer Perforation | 12.8% |
| 120 | Gastric ulcer | 12.8% |
| 121 | Bone neoplasms | 12.7% |
| 122 | Skin Neoplasms | 12.7% |
| 123 | Hematologic Neoplasms | 12.7% |
| 124 | Barrett Esophagus | 12.5% |
| 125 | Splenic Neoplasms | 12.5% |
| 126 | Appendicitis | 12.4% |
| 127 | Parathyroid Neoplasms | 11.9% |
| 128 | Thyroid Neoplasm | 11.9% |
| 129 | Thyroid carcinoma | 11.9% |
| 130 | Hepatitis, Viral, Animal | 11.8% |
| 131 | Colonic Pseudo-Obstruction | 11.7% |
| 132 | Hepatitis E | 11.6% |
| 133 | Variegate Porphyria | 11.5% |
| 134 | Acute intermittent porphyria | 11.5% |
| 135 | Porphyria Cutanea Tarda | 11.5% |
| 136 | Hepatitis B | 11.4% |
| 137 | Hepatitis C | 11.4% |
| 138 | Hepatitis A | 11.4% |
| 139 | Hepatic Encephalopathy | 11.2% |
| 140 | Enterocolitis, Pseudomembranous | 11.2% |
| 141 | pseudomembranous colitis | 11.2% |
| 142 | Dysentery, Bacillary | 11.2% |
| 143 | Anus, Imperforate | 11.1% |
| 144 | Gastrointestinal Hemorrhage | 11.1% |
| 145 | Hemoperitoneum | 11.1% |
| 146 | Mesenteric Panniculitis | 11.1% |
| 147 | Panniculitis, Peritoneal | 11.1% |
| 148 | Peritonitis | 11.1% |
| 149 | Peritoneal Fibrosis | 11.1% |
| 150 | Encapsulating Peritoneal Sclerosis | 11.1% |
| 151 | Anorectal Malformations | 11.1% |
| 152 | Biliary Fistula | 11% |
| 153 | Gastric Fistula | 11% |
| 154 | Tuberculosis, Gastrointestinal | 11% |
| 155 | Pancreatic Pseudocyst | 11% |
| 156 | Liver diseases | 10.9% |
| 157 | Colitis, Ischemic | 10.8% |
| 158 | Paraneoplastic Encephalomyelitis | 10.5% |
| 159 | Multiple Endocrine Neoplasia | 10.4% |
| 160 | Cecal Diseases | 10.3% |
| 161 | Cholangitis | 10.3% |
| 162 | Cholecystitis | 10.3% |
| 163 | Cholestasis | 10.3% |
| 164 | Colonic Diseases | 10.3% |
| 165 | Common Bile Duct Diseases | 10.3% |
| 166 | Esophageal Stenosis | 10.3% |
| 167 | Ileal Diseases | 10.3% |
| 168 | Intestinal Obstruction | 10.3% |
| 169 | Intestinal Perforation | 10.3% |
| 170 | Jejunal Diseases | 10.3% |
| 171 | Pneumatosis Cystoides Intestinalis | 10.3% |
| 172 | Rectal Diseases | 10.3% |
| 173 | Retroperitoneal Neoplasms | 10.3% |
| 174 | Gastric Dilatation | 10.3% |
| 175 | Tracheal Neoplasms | 10.3% |
| 176 | Pancreatitis, Chronic | 10.3% |
| 177 | Gastric outlet obstruction | 10.3% |
| 178 | Cronkhite-Canada Syndrome | 10.3% |
| 179 | Intestinal Polyposis | 10.3% |
| 180 | Mammary Neoplasms, Experimental | 10.3% |
| 181 | Acanthoma | 10.2% |
| 182 | Liver neoplasms | 9.3% |
| 183 | Hamartoma | 9.1% |
| 184 | Neoplasms, Hormone-Dependent | 9.1% |
| 185 | Neoplasms, Multiple Primary | 9.1% |
| 186 | Paraneoplastic Syndromes | 9.1% |
| 187 | Precancerous Conditions | 9.1% |
| 188 | Neoplasms, Second Primary | 9.1% |
| 189 | Digestive System Neoplasms | 8.7% |
| 190 | Thyroid Nodule | 8.7% |
| 191 | Esophageal Perforation | 8.6% |
| 192 | Intestinal Diseases, Parasitic | 8.6% |
| 193 | Cholestasis, Extrahepatic | 8.5% |
| 194 | Biliary Dyskinesia | 8.5% |
| 195 | Cholangitis, Sclerosing | 8.5% |
| 196 | Colonic Diseases, Functional | 8.5% |
| 197 | Esophageal motility disorders | 8.5% |
| 198 | Fecal Incontinence | 8.5% |
| 199 | Fecal Impaction | 8.5% |
| 200 | Intussusception | 8.5% |
| 201 | Mallory-Weiss Syndrome | 8.5% |
| 202 | Megacolon | 8.5% |
| 203 | Pyloric Stenosis | 8.5% |
| 204 | Acalculous Cholecystitis | 8.5% |
| 205 | Ileus | 8.5% |
| 206 | Meconium ileus | 8.5% |
| 207 | Carcinoma, Lobular | 8.4% |
| 208 | Deglutition Disorders | 8.3% |
| 209 | Mouth Neoplasms | 8.3% |
| 210 | Central Nervous System Neoplasms | 8.3% |
| 211 | Vascular Neoplasms | 8.3% |
| 212 | Thymus Neoplasms | 8.3% |
| 213 | Achlorhydria | 8.2% |
| 214 | Genital Neoplasms, Female | 8.2% |
| 215 | Gastric Antral Vascular Ectasia | 8.2% |
| 216 | Zellweger Syndrome | 8.2% |
| 217 | Peptic Ulcer Hemorrhage | 8.2% |
| 218 | Gastroparesis | 8.2% |
| 219 | Breast Neoplasms, Male | 8.2% |
| 220 | Pancreatitis, Alcoholic | 8.2% |
| 221 | Triple Negative Breast Neoplasms | 8.2% |
| 222 | Cystic Fibrosis | 8.1% |
| 223 | Testicular Neoplasms | 7.9% |
| 224 | Congenital Hyperinsulinism | 7.8% |
| 225 | Peutz-Jeghers Syndrome | 7.7% |
| 226 | Esophageal Achalasia | 7.7% |
| 227 | Anal Fissure | 7.7% |
| 228 | Intestinal Pseudo-Obstruction | 7.7% |
| 229 | Irritable Bowel Syndrome | 7.7% |
| 230 | Superior Mesenteric Artery Syndrome | 7.7% |
| 231 | Emphysematous Cholecystitis | 7.7% |
| 232 | Neurogenic Bowel | 7.7% |
| 233 | Sphincter of Oddi Dysfunction | 7.7% |
| 234 | Anal Ulcer | 7.7% |
| 235 | Liver Neoplasms, Experimental | 7.6% |
| 236 | Hepatolenticular Degeneration | 7.6% |
| 237 | Meningioma | 7.4% |
| 238 | Thymoma | 7.3% |
| 239 | Cyst | 7.2% |
| 240 | Neoplastic Processes | 7.2% |
| 241 | Neoplastic Syndromes, Hereditary | 7.2% |
| 242 | Pregnancy Complications, Neoplastic | 7.2% |
| 243 | Hepatocellular Adenoma | 7.2% |
| 244 | Multiple Endocrine Neoplasia Type 1 | 7.1% |
| 245 | Neoplasms, Experimental | 7.1% |
| 246 | Adrenal Gland Neoplasms | 7% |
| 247 | Genital Neoplasms, Male | 7% |
| 248 | Uveal Neoplasms | 7% |
| 249 | Hemorrhoids | 6.9% |
| 250 | Urologic Neoplasms | 6.9% |
| 251 | Melena | 6.9% |
| 252 | Rift Valley Fever | 6.8% |
| 253 | Sebaceous Gland Neoplasms | 6.8% |
| 254 | Spinal Neoplasms | 6.8% |
| 255 | Bone Marrow Neoplasms | 6.8% |
| 256 | Afferent Loop Syndrome | 6.8% |
| 257 | Celiac Disease | 6.8% |
| 258 | Short Bowel Syndrome | 6.8% |
| 259 | Sprue, Tropical | 6.8% |
| 260 | Steatorrhea | 6.8% |
| 261 | Rectocele | 6.8% |
| 262 | Sprue | 6.8% |
| 263 | Diverticulitis | 6.8% |
| 264 | Dumping Syndrome | 6.8% |
| 265 | Rectal Prolapse | 6.8% |
| 266 | Hematemesis | 6.7% |
| 267 | Carcinoma 256, Walker | 6.5% |
| 268 | Acoustic Neuroma | 6.4% |
| 269 | Leukoplakia, Oral | 6.3% |
| 270 | Paraneoplastic Cerebellar Degeneration | 6.2% |
| 271 | Carcinoma, Ehrlich Tumor | 6.2% |
| 272 | Dermoid Cyst | 6.2% |
| 273 | Carcinoma, Lewis Lung | 6.2% |
| 274 | Nose Neoplasms | 6.2% |
| 275 | Meningeal Neoplasms | 6.1% |
| 276 | Palatal Neoplasms | 6.1% |
| 277 | Pruritus Ani | 6.1% |
| 278 | Neoplasms, Radiation-Induced | 5.9% |
| 279 | Laryngopharyngeal Reflux | 5.8% |
| 280 | Giardiasis | 5.8% |
| 281 | Trophoblastic Neoplasms | 5.7% |
| 282 | Nesidioblastosis | 5.7% |
| 283 | Leukemia, Experimental | 5.7% |
| 284 | Retinoblastoma | 5.7% |
| 285 | Diverticulum | 5.7% |
| 286 | Diverticulosis | 5.7% |
| 287 | Melanoma, Experimental | 5.6% |
| 288 | Neoplasms, Neuroepithelial | 5.6% |
| 289 | Gliomatosis cerebri | 5.6% |
| 290 | Pituitary Adenoma | 5.6% |
| 291 | Pituitary Neoplasms | 5.6% |
| 292 | Neuroectodermal Tumors | 5.5% |
| 293 | Leydig Cell Tumor | 5.5% |
| 294 | Limbic Encephalitis | 5.4% |
| 295 | Optic Nerve Glioma | 5.3% |
| 296 | Nephroblastoma | 5.3% |
| 297 | Erythroplasia | 5.3% |
| 298 | Follicular cyst | 5.3% |
| 299 | leukemia | 5.3% |
| 300 | Mucocele | 5.3% |
| 301 | Neoplasms, Germ Cell and Embryonal | 5.3% |
| 302 | Neoplasms, Glandular and Epithelial | 5.3% |
| 303 | Pilonidal Cyst | 5.3% |
| 304 | Thyroglossal Cyst | 5.3% |
| 305 | Synovial Cyst | 5.3% |
| 306 | Germ Cell Cancer | 5.3% |
| 307 | Aberrant Crypt Foci | 5.3% |
| 308 | Ear Neoplasms | 5.2% |
| 309 | Eyelid Neoplasms | 5.2% |
| 310 | Lung Neoplasms | 5.2% |
| 311 | Pleural Neoplasms | 5.2% |
| 312 | Tuberous Sclerosis | 5.1% |
| 313 | Sarcoma, Experimental | 5.1% |
| 314 | Brain Neoplasms | 5.1% |
| 315 | Salivary Gland Neoplasms | 5.1% |
| 316 | Spinal Cord Neoplasms | 5.1% |
| 317 | Tongue Neoplasms | 5.1% |
| 318 | ovarian neoplasm | 5.1% |
| 319 | Medulloblastoma | 5.1% |
| 320 | Meningeal Carcinomatosis | 5.1% |
| 321 | melanoma | 5% |
| 322 | Uterine Neoplasms | 5% |
| 323 | Vaginal Neoplasms | 5% |
| 324 | Vulvar Neoplasms | 5% |
| 325 | Uterine Cancer | 5% |
| 326 | Fallopian Tube Neoplasms | 5% |
| 327 | Prolactinoma | 5% |
| 328 | Growth Hormone-Secreting Pituitary Adenoma | 5% |
| 329 | Leukemia, Radiation-Induced | 4.9% |
| 330 | Lambert-Eaton Myasthenic Syndrome | 4.9% |
| 331 | Lactose Intolerance | 4.8% |
| 332 | Carcinosarcoma | 4.8% |
| 333 | Hemangiosarcoma | 4.8% |
| 334 | Leukemia L1210 | 4.8% |
| 335 | Leukemia P388 | 4.8% |
| 336 | lymphangiosarcoma | 4.8% |
| 337 | Choriocarcinoma | 4.5% |
| 338 | Pharyngeal Neoplasms | 4.5% |
| 339 | Adenoma, Acidophil | 4.4% |
| 340 | Ganglioneuroma | 4.4% |
| 341 | Glioma | 4.4% |
| 342 | Malignant Glioma | 4.4% |
| 343 | granulosa cell tumor | 4.4% |
| 344 | Carcinoma, Ovarian Epithelial | 4.4% |
| 345 | Sarcoma 180 | 4.4% |
| 346 | Opsoclonus-Myoclonus Syndrome | 4.4% |
| 347 | Central Nervous System Cysts | 4.4% |
| 348 | Penile Neoplasms | 4.3% |
| 349 | Prostatic Neoplasms | 4.3% |
| 350 | Polycythemia Vera | 4.3% |
| 351 | Bronchial Neoplasms | 4.3% |
| 352 | Leukoplakia | 4.2% |
| 353 | Lymphocele | 4.2% |
| 354 | Multiple Pulmonary Nodules | 4.2% |
| 355 | Mesoblastic Nephroma | 4.2% |
| 356 | Supratentorial Neoplasms | 4.2% |
| 357 | Breast Cyst | 4.2% |
| 358 | Histiocytic Disorders, Malignant | 4.2% |
| 359 | Actinic keratosis | 4.2% |
| 360 | Mediastinal Cyst | 4.2% |
| 361 | Neoplasm Invasiveness | 4.2% |
| 362 | Neoplasm Metastasis | 4.2% |
| 363 | Neoplasm Recurrence, Local | 4.2% |
| 364 | Parovarian Cyst | 4.2% |
| 365 | Pericardial Cyst | 4.2% |
| 366 | Thymic Cyst | 4.2% |
| 367 | Carcinogenesis | 4.2% |
| 368 | Myxoid cyst | 4.2% |
| 369 | Metastasis | 4.2% |
| 370 | Carcinoid Tumor | 4.2% |
| 371 | Endometrial Neoplasms | 4.2% |
| 372 | Neurilemmoma | 4.2% |
| 373 | Hutchinson's Melanotic Freckle | 4.2% |
| 374 | Melanoma, Amelanotic | 4.2% |
| 375 | Adrenocortical carcinoma | 4.1% |
| 376 | Lymphomatoid Granulomatosis | 4.1% |
| 377 | Basal cell carcinoma | 4.1% |
| 378 | Carcinoma, Papillary | 4.1% |
| 379 | Squamous cell carcinoma | 4.1% |
| 380 | Chondrosarcoma | 4.1% |
| 381 | Craniopharyngioma | 4.1% |
| 382 | Cystadenoma | 4.1% |
| 383 | leiomyosarcoma | 4.1% |
| 384 | liposarcoma | 4.1% |
| 385 | Mesothelioma | 4.1% |
| 386 | synovial sarcoma | 4.1% |
| 387 | Neuroectodermal Tumor, Melanotic | 4.1% |
| 388 | Angiomyolipoma | 4.1% |
| 389 | Clear Cell Sarcoma of Soft Tissue | 4.1% |
| 390 | Alveolar Soft Part Sarcoma | 4.1% |
| 391 | Neuroendocrine Tumors | 4.1% |
| 392 | Sarcoma, Myeloid | 4.1% |
| 393 | Carcinoma, Basal Cell | 4.1% |
| 394 | Myelitis, Transverse | 3.9% |
| 395 | Leukemia, Plasma Cell | 3.9% |
| 396 | Laryngeal neoplasm | 3.9% |
| 397 | Astrocytoma | 3.9% |
| 398 | Ependymoma | 3.9% |
| 399 | oligodendroglioma | 3.9% |
| 400 | Ganglioglioma | 3.9% |
| 401 | gliosarcoma | 3.9% |
| 402 | Anaplastic astrocytoma | 3.9% |
| 403 | Anaplastic Oligodendroglioma | 3.9% |
| 404 | Composite Lymphoma | 3.8% |
| 405 | Cryptosporidiosis | 3.8% |
| 406 | Bladder Neoplasm | 3.8% |
| 407 | Kidney Neoplasm | 3.8% |
| 408 | Ureteral Neoplasms | 3.8% |
| 409 | Urethral Neoplasms | 3.8% |
| 410 | Basal Cell Nevus Syndrome | 3.7% |
| 411 | Brain Stem Neoplasms | 3.7% |
| 412 | Malignant Carcinoid Syndrome | 3.7% |
| 413 | Cystadenocarcinoma | 3.7% |
| 414 | Fibrosarcoma | 3.7% |
| 415 | Osteosarcoma | 3.7% |
| 416 | Mucoepidermoid Carcinoma | 3.7% |
| 417 | Renal Cell Carcinoma | 3.6% |
| 418 | Papillary Renal Cell Carcinoma | 3.6% |
| 419 | Hypopharyngeal Neoplasms | 3.6% |
| 420 | Pleural Effusion, Malignant | 3.6% |
| 421 | Hypopharyngeal Cancer | 3.6% |
| 422 | Glioblastoma | 3.6% |
| 423 | Neuroblastoma | 3.6% |
| 424 | Glioblastoma Multiforme | 3.6% |
| 425 | Parotid Neoplasms | 3.6% |
| 426 | Prostatic Neoplasms, Castration-Resistant | 3.6% |
| 427 | Nelson Syndrome | 3.5% |
| 428 | Adenofibroma | 3.5% |
| 429 | Fibroadenoma | 3.5% |
| 430 | Malignant Fibrous Histiocytoma | 3.5% |
| 431 | Choroid Plexus Papilloma | 3.5% |
| 432 | Adenoma | 3.4% |
| 433 | Ameloblastoma | 3.4% |
| 434 | Angiokeratoma | 3.4% |
| 435 | Carcinoma | 3.4% |
| 436 | Chordoma | 3.4% |
| 437 | Hemangioma | 3.4% |
| 438 | hemangiopericytoma | 3.4% |
| 439 | Lymphangioma | 3.4% |
| 440 | Lymphoma | 3.4% |
| 441 | Mesenchymoma | 3.4% |
| 442 | Nevus | 3.4% |
| 443 | Teratoma | 3.4% |
| 444 | Hepatoblastoma | 3.4% |
| 445 | Mixed Tumor, Mullerian | 3.4% |
| 446 | Germinoma | 3.4% |
| 447 | Teratocarcinoma | 3.4% |
| 448 | Angiofibroma | 3.4% |
| 449 | Sarcoma | 3.4% |
| 450 | Epithelioma | 3.4% |
| 451 | Ganglioneuroblastoma | 3.4% |
| 452 | Corpus Luteum Cyst | 3.4% |
| 453 | Ovarian Cysts | 3.4% |
| 454 | Carcinoma, Endometrioid | 3.4% |
| 455 | Bowen's Disease | 3.4% |
| 456 | Paraganglioma | 3.4% |
| 457 | Rhabdomyosarcoma | 3.4% |
| 458 | Giant Cell Tumor of Bone | 3.4% |
| 459 | CREST Syndrome | 3.3% |
| 460 | Nasopharyngeal carcinoma | 3.2% |
| 461 | Tonsillar Neoplasms | 3.2% |
| 462 | Cerebellar Neoplasms | 3.2% |
| 463 | Dermatofibrosarcoma | 3.2% |
| 464 | Dermatofibrosarcoma Protuberans | 3.2% |
| 465 | Endometrial Stromal Sarcoma | 3.1% |
| 466 | Hydatidiform Mole | 3.1% |
| 467 | Carcinoid Heart Disease | 3% |
| 468 | Pheochromocytoma | 3% |
| 469 | Alveolar rhabdomyosarcoma | 3% |
| 470 | Denys-Drash Syndrome | 3% |
| 471 | Neurofibrosarcoma | 3% |
| 472 | Lymphangioleiomyomatosis | 2.9% |
| 473 | Nasopharyngeal Neoplasms | 2.8% |
| 474 | Plasmacytoma | 2.7% |
| 475 | Malignant histiocytosis | 2.7% |
| 476 | Lymphatic Metastasis | 2.7% |
| 477 | Neoplasms, Unknown Primary | 2.7% |
| 478 | Leukemic Infiltration | 2.7% |
| 479 | Histiocytic sarcoma | 2.7% |
| 480 | Neoplasm Micrometastasis | 2.7% |
| 481 | Adenocarcinoma | 2.6% |
| 482 | Carcinoma in Situ | 2.6% |
| 483 | Carcinoma, Transitional Cell | 2.6% |
| 484 | Phyllodes Tumor | 2.6% |
| 485 | Dysgerminoma | 2.6% |
| 486 | Hemangioendothelioma | 2.6% |
| 487 | Lipoma | 2.6% |
| 488 | Myoma | 2.6% |
| 489 | Myxoma | 2.6% |
| 490 | Neuroma | 2.6% |
| 491 | Papilloma | 2.6% |
| 492 | Pseudomyxoma Peritonei | 2.6% |
| 493 | Seminoma | 2.6% |
| 494 | Papillomatosis | 2.6% |
| 495 | Angiolipoma | 2.6% |
| 496 | Myelolipoma | 2.6% |
| 497 | Neoplasms, Bone Tissue | 2.6% |
| 498 | Neoplasms, Fibrous Tissue | 2.6% |
| 499 | Smooth Muscle Tumor | 2.6% |
| 500 | Adenomatosis, Pulmonary | 2.6% |
| 501 | Adenomatous Polyps | 2.6% |
| 502 | Carcinoma, Large Cell | 2.6% |
| 503 | Carcinoma, Small Cell | 2.6% |
| 504 | Desmoplastic Small Round Cell Tumor | 2.6% |
| 505 | Chondroma | 2.6% |
| 506 | Enchondroma | 2.6% |
| 507 | Paranasal Sinus Neoplasms | 2.5% |
| 508 | Hodgkin Disease | 2.2% |
| 509 | Lymphoma, Non-Hodgkin | 2.2% |
| 510 | Polycystic Ovary Syndrome | 2.2% |
| 511 | Maxillary Sinus Neoplasms | 2.2% |
| 512 | Adenoid Cystic Carcinoma | 2.1% |
| 513 | fibroma | 2.1% |
| 514 | Fibromatosis | 2.1% |
| 515 | Osteoblastoma | 2.1% |
| 516 | Osteoma | 2.1% |
| 517 | Rhabdomyoma | 2.1% |
| 518 | Chondromatosis | 2.1% |
| 519 | Adenocarcinoma, Clear Cell | 2.1% |
| 520 | Cholangiocarcinoma | 2.1% |
| 521 | Cervical Intraepithelial Neoplasia | 2.1% |
| 522 | Hemangioblastoma | 2.1% |
| 523 | Lymphoma, Extranodal NK-T-Cell | 2.1% |
| 524 | Leukemia, Myelomonocytic, Chronic | 2% |
| 525 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 2% |
| 526 | Primary amyloidosis | 1.9% |
| 527 | Fibromatosis, Aggressive | 1.9% |
| 528 | Fibromatosis, Abdominal | 1.9% |
| 529 | Klatskin Tumor | 1.9% |
| 530 | Xeroderma Pigmentosum | 1.9% |
| 531 | Mastocytosis | 1.7% |
| 532 | Sturge-Weber Syndrome | 1.7% |
| 533 | Cell Transformation, Viral | 1.7% |
| 534 | Mastocytoma | 1.7% |
| 535 | Hemangioma, Cavernous | 1.7% |
| 536 | Mastocytosis, Systemic | 1.7% |
| 537 | Leukemia, Myeloid, Chronic-Phase | 1.7% |
| 538 | Leukemia, T-Cell | 1.7% |
| 539 | Leukemia, B-Cell | 1.7% |
| 540 | neurofibroma | 1.7% |
| 541 | Lymphoma, Follicular | 1.7% |
| 542 | T-Cell Lymphoma | 1.7% |
| 543 | Mantle cell lymphoma | 1.7% |
| 544 | Waldenstrom Macroglobulinemia | 1.5% |
| 545 | Multiple Myeloma | 1.5% |
| 546 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1.4% |
| 547 | Leukemia, Large Granular Lymphocytic | 1.4% |
| 548 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1.4% |
| 549 | Lymphoma, T-Cell, Cutaneous | 1.4% |
| 550 | Lymphoma, AIDS-Related | 1.4% |
| 551 | Enteropathy-Associated T-Cell Lymphoma | 1.4% |
| 552 | Primary Effusion Lymphoma | 1.4% |
| 553 | Dupuytren Contracture | 1.3% |
| 554 | Urticaria Pigmentosa | 1.3% |
| 555 | Mycosis Fungoides | 1.2% |
| 556 | Lymphomatoid Papulosis | 1.2% |
| 557 | Plasmablastic lymphoma | 1.2% |
| 558 | Burkitt Lymphoma | 1% |
| 559 | Sezary Syndrome | 0.9% |
| 560 | Radicular Cyst | 0.9% |
